Synergic Effect of Prostacyclin (PGI2) and α-Blocking-Agent on Adrenalin-Induced Human Platelet Aggregation

Thromb Haemost 1980; 44(02): 106
DOI: 10.1055/s-0038-1650095

Letter of the Editor

Schattauer GmbH Stuttgart

Synergic Effect of Prostacyclin (PGI₂) and α-Blocking-Agent on Adrenalin-Induced Human Platelet Aggregation

E Pogliani

^*Clinica Medica I dell'Universitá Ospedale Policlinico, Milano, Italy

,

R Fantasia

^*Clinica Medica I dell'Universitá Ospedale Policlinico, Milano, Italy

,

M Colombi

^*Clinica Medica I dell'Universitá Ospedale Policlinico, Milano, Italy

,

C Praga

^**Farmitalia-Carlo Erba, Milano, Italy

References
1 Salzman EW, Levine L. Cyclic 3', 5'-adenosin monophosphate in human blood platelets. II. Effect of N6-2-0-dibutyryl cyclic 3', 5'-adenosine monophosphate on platelet function. J Clin Invest 1971; 50: 131-141
2 Salzman EW. Cyclic AMP and platelet function. N Engl. J Med 1972; 286: 358-363
3 Praga C, Pogliani E. Effect of nicergoline on human platelet aggregation in vitro. Acta Med Scand (Suppl) 1970; 525: 263-266
4 Pogliani E, Delia VolpeA, Ferrari R, Recalcati P, Praga C. Inhibition of human platelet aggregation by oral administration of nicergoline. A double blind study. Farmaco (Prat) 1975; 30: 630-640
5 Moncada S, Gryglewski RJ, Runting S, Vane JR. A lipid peroxide inhibits the enzyme in blood vessels microsome that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevent platelet aggregation. Prostaglandins 1976; 12: 715-737
6 Kafka MS, Talhman JF, Smith CC. Alpha-adrenergic receptors on human platelets. Life Sci 1977; 21: 1429-1438